Study of Safety and Tolerability of DCR HBVS

Clinical trial NCT03772249 · COMPLETED

Trial details

NCT number: NCT03772249
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2018-12-28
Primary completion: 2022-07-12
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.